Sharescart Research Club logo

Fischer Medical Overview

Fischer Chemic Ltd provides consultancy services in India. Its activities also include AMC services. The agency incorporated in 1993 and is based in Mumbai, India.

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Fischer Medical Key Financials

Market Cap ₹2430 Cr.

Stock P/E 2011.9

P/B 6.2

Current Price ₹37.1

Book Value ₹ 6

Face Value 1

52W High ₹124.2

Dividend Yield 0.01%

52W Low ₹ 32.1

Fischer Medical Share Price

₹ | |

Volume
Price

Fischer Medical Quarterly Price

Show Value Show %

Fischer Medical Peer Comparison

Fischer Medical Quarterly Results

#(Fig in Cr.) Jun 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 0 21 10 40 12 49 23 86 101
Other Income 0 0 1 0 0 0 7 2 1
Total Income 0 21 11 40 12 49 31 89 102
Total Expenditure 0 18 10 39 11 47 19 70 80
Operating Profit 0 3 0 1 1 3 12 19 23
Interest 0 0 0 0 0 0 1 1 1
Depreciation 0 0 0 0 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 -0 0 0
Profit Before Tax 0 3 0 0 0 2 10 17 21
Provision for Tax 0 0 0 -0 0 1 5 3 2
Profit After Tax 0 3 -0 0 -0 1 5 14 19
Adjustments 0 0 0 -0 -0 -0 0 -0 -0
Profit After Adjustments 0 3 -0 0 -0 1 5 14 19
Adjusted Earnings Per Share 0 0 -0 0 -0 0 0.1 0.2 0.3

Fischer Medical Profit & Loss

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 21 111 259
Other Income 0 1 1 10
Total Income 0 21 112 271
Total Expenditure 0 19 107 216
Operating Profit 0 2 5 57
Interest 0 0 0 3
Depreciation 0 0 2 4
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax -0 2 2 50
Provision for Tax 0 0 1 11
Profit After Tax -0 2 1 39
Adjustments 0 -0 0 0
Profit After Adjustments -0 1 1 39
Adjusted Earnings Per Share -0.2 0 0 0.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 429% 0% 0% 0%
Operating Profit CAGR 150% 0% 0% 0%
PAT CAGR -50% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -53% 58% 71% 68%
ROE Average 1% 2% 2% 2%
ROCE Average 1% 4% 4% 4%

Fischer Medical Balance Sheet

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -0 81 338
Minority's Interest 0 0 0
Borrowings 1 0 0
Other Non-Current Liabilities -0 1 17
Total Current Liabilities 0 4 102
Total Liabilities 0 86 457
Fixed Assets 0 15 24
Other Non-Current Assets 0 1 68
Total Current Assets 0 70 365
Total Assets 0 86 457

Fischer Medical Cash Flow

#(Fig in Cr.) Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1
Cash Flow from Operating Activities 0 -7 -87
Cash Flow from Investing Activities 0 -31 -125
Cash Flow from Financing Activities 0 37 315
Net Cash Inflow / Outflow 0 -2 103
Closing Cash & Cash Equivalent 0 1 104

Fischer Medical Ratios

# Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -0.21 0.03 0.02
CEPS(Rs) -0.21 0.04 0.04
DPS(Rs) 0 0 0.01
Book NAV/Share(Rs) -1.55 1.5 4.82
Core EBITDA Margin(%) 8.47 8.86 3.02
EBIT Margin(%) 8.47 10.38 2.45
Pre Tax Margin(%) -0.72 10.06 2.01
PAT Margin (%) -20.33 8.76 1.09
Cash Profit Margin (%) -20.33 9.63 2.57
ROA(%) -14.72 4.25 0.44
ROE(%) 0 4.6 0.62
ROCE(%) 4.97 5.35 1.13
Receivable days 346.9 200.41 163.11
Inventory Days 0 77.86 22.49
Payable days 0 24.06 45.45
PER(x) 0 2421.12 3869.4
Price/Book(x) -5.43 41.65 18.64
Dividend Yield(%) 0 0 0.01
EV/Net Sales(x) 11.03 157.47 50.01
EV/Core EBITDA(x) 130.31 1399.44 1144.95
Net Sales Growth(%) 0 0 427.61
EBIT Growth(%) 0 0 24.67
PAT Growth(%) 0 5135.34 -34.28
EPS Growth(%) 0 112.16 -10.08
Debt/Equity(x) -2.15 0 0.2
Current Ratio(x) 5.18 18.37 3.59
Quick Ratio(x) 5.18 17.21 3.5
Interest Cover(x) 0.92 32.23 5.5
Total Debt/Mcap(x) 0.4 0 0.01

Fischer Medical Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 0 0 74.91 74.91 74.91 62.81 61.8 61.8 61.8 62.15
FII 0 5.07 5.07 5.07 5.07 5.23 5.55 5.57 4.85 4.97
DII 0 1.68 1.68 1.68 1.68 1.44 1.42 1.42 1.36 1.38
Public 100 93.24 18.33 18.33 18.33 30.51 31.23 31.21 31.99 31.5
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Fischer Medical News

Fischer Medical Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Company has a low return on equity of 2% over the last 3 years.
  • Debtor days have increased from 24.06 to 45.45days.
  • Stock is trading at 6.2 times its book value.
whatsapp